ASP Isotopes Inc. (NASDAQ:ASPI) Shares Sold by GSA Capital Partners LLP

Key Points

• GSA Capital Partners LLP reduced its holdings in ASP Isotopes Inc. by 29.6%, selling 239,133 shares, which makes the stock only 0.2% of its portfolio.
• ASP Isotopes has seen recent increases in institutional investments, with Nuveen Asset Management LLC boosting its position by 672.1% and JPMorgan Chase & Co. by 854.6% in the fourth quarter.
• Analysts at Canaccord Genuity Group have raised their price target for ASP Isotopes from $8.50 to $11.00 and maintained a "buy" rating on the stock.

GSA Capital Partners LLP decreased its holdings in ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) by 29.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 569,578 shares of the company's stock after selling 239,133 shares during the period. ASP Isotopes comprises approximately 0.2% of GSA Capital Partners LLP's portfolio, making the stock its 20th largest position. GSA Capital Partners LLP owned 0.76% of ASP Isotopes worth $2,671,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of ASPI. CenterBook Partners LP acquired a new position in shares of ASP Isotopes in the fourth quarter worth $6,800,000. AWM Investment Company Inc. grew its stake in shares of ASP Isotopes by 16.0% in the fourth quarter. AWM Investment Company Inc. now owns 4,246,186 shares of the company's stock worth $19,235,000 after acquiring an additional 586,600 shares in the last quarter. Two Sigma Investments LP acquired a new position in shares of ASP Isotopes in the fourth quarter worth $1,980,000. Nuveen Asset Management LLC lifted its position in shares of ASP Isotopes by 672.1% during the 4th quarter. Nuveen Asset Management LLC now owns 413,346 shares of the company's stock worth $1,872,000 after purchasing an additional 359,811 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its position in shares of ASP Isotopes by 854.6% during the 4th quarter. JPMorgan Chase & Co. now owns 211,893 shares of the company's stock worth $960,000 after purchasing an additional 189,697 shares during the last quarter. Institutional investors and hedge funds own 16.80% of the company's stock.

ASP Isotopes Trading Down 3.5%

Shares of ASP Isotopes stock opened at $10.10 on Tuesday. ASP Isotopes Inc. has a 52-week low of $1.86 and a 52-week high of $10.82. The company has a quick ratio of 7.17, a current ratio of 7.21 and a debt-to-equity ratio of 0.80. The company's 50-day simple moving average is $8.14 and its 200-day simple moving average is $6.26. The firm has a market cap of $847.39 million, a price-to-earnings ratio of -16.56 and a beta of 3.35.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group boosted their price target on shares of ASP Isotopes from $8.50 to $11.00 and gave the company a "buy" rating in a research report on Wednesday, May 21st.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Want to see what other hedge funds are holding ASPI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ASP Isotopes Inc. (NASDAQ:ASPI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.